NCT05087524 is a NA clinical trial of BinaxNOW Ag Card in SARS-CoV2 Infection, sponsored by University of Wisconsin, Madison.

Who is sponsoring NCT05087524?

NCT05087524 is sponsored by University of Wisconsin, Madison.

What drugs are being tested in NCT05087524?

Interventions in NCT05087524: BinaxNOW Ag Card.

What condition does NCT05087524 study?

NCT05087524 studies SARS-CoV2 Infection, COVID-19.

Is NCT05087524 still recruiting?

NCT05087524 is currently terminated. Last updated 28 January 2022.

Are results published for NCT05087524?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2022-01-28 · How we verify

NCT05087524

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BinaxNOW for Evaluating Children for Infection With SARS-CoV-2 (COVID-19)

Terminated NA Results posted Last updated 28 January 2022

What this trial tests

NA trial testing BinaxNOW Ag Card in SARS-CoV2 Infection in 65 participants. Terminated before completion.

Timeline

9 January 2021

Primary endpoint
8 April 2021

8 April 2021

Quick facts

Lead sponsor	University of Wisconsin, Madison
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	65
Start date	9 January 2021
Primary completion	8 April 2021
Estimated completion	8 April 2021
Sites	1 location across United States

Drugs / interventions tested

BinaxNOW Ag Card

Conditions studied

SARS-CoV2 Infection — all drugs for SARS-CoV2 Infection →
COVID-19 — all drugs for COVID-19 →

Sponsor

University of Wisconsin, Madison

Who can join

Adults 5 to 65, any sex, with SARS-CoV2 Infection or COVID-19. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Number of Tests Taken Per Participant Primary · up to 8 weeks

Feasibility BinaxNOW surveillance testing will be measured by the number of test taken per participant. Greater than 1 test per participant is an indicator of compliance with repeat surveillance testing.

Group	Value	95% CI
BinaxNOW Surveillance	5.11	± 2.56

Number of Positive SARS-CoV-2 BinaxNOW Tests Confirmed by PCR Testing Primary · up to 5 weeks

The specificity of positive tests for SARS-CoV-2 obtained for diagnosis or surveillance compared to traditional PCR diagnostic testing.

Group	Value	95% CI
BinaxNOW Surveillance	0

Sponsor's own description

This is a study of the BinaxNOW Covid-19 Ag Card as a method to rapidly identify SARS-CoV-2 infection in asymptomatic children, teachers, and other school staff for exclusion. 240 students and 80 teachers in the Madison Metropolitan School District (MMSD) will be enrolled and can expect to be on study for up to 8 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for SARS-CoV2 Infection

Currently open trials in the same condition.

NCT05852873 — PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway · Phase 3 · active not recruiting
NCT04910269 — Outpatient Treatment With Anti-Coronavirus Immunoglobulin · Phase 3 · recruiting
NCT04830852 — Pediatric COVID Outcomes Study (PECOS) · active not recruiting
NCT04844242 — MISC COVID-19 Study in Pediatric Population · recruiting

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

NCT07440004 — Testing a Digital Mindfulness Program to Support People Experiencing Suicidal Thoughts · Phase 1 · recruiting
NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
NCT07475104 — Redesigning Surgical Care for Patients in Wisconsin · NA · enrolling by invitation
NCT07470723 — The ORIGIN-FH Study · NA · recruiting
NCT06975657 — Well-being Skills for Reentry · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05087524 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Wisconsin, Madison
Last refreshed: 28 January 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05087524.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing